PT Ekadharma International Tbk Logo

PT Ekadharma International Tbk

EKAD.JK

(0.5)
Stock Price

236 IDR

5.35% ROA

6.16% ROE

13.34x PER

Market Cap.

873.470.000.000 IDR

0% DER

3.6% Yield

12.46% NPM

PT Ekadharma International Tbk Stock Analysis

PT Ekadharma International Tbk Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

PT Ekadharma International Tbk Fundamental Stock Analysis
# Analysis Rating
1 Dividend

The company's consistent dividend distribution over the past five years reflects its dedication to providing shareholders with steady returns, making it an appealing choice for investors seeking income stability.

2 ROE

Unidentified ROE

3 ROA

Unidentified ROA

4 PBV

Unidentified ROA

5 DER

Unidentified DER

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Graham Number

Unidentified Graham Number

10 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

PT Ekadharma International Tbk Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

PT Ekadharma International Tbk Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

PT Ekadharma International Tbk Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

PT Ekadharma International Tbk Revenue
Year Revenue Growth
2012 385.037.050.333
2013 418.668.758.096 8.03%
2014 526.573.620.056 20.49%
2015 531.537.606.572 0.93%
2016 568.638.832.579 6.52%
2017 643.591.823.505 11.65%
2018 739.578.860.399 12.98%
2019 758.299.364.555 2.47%
2020 671.540.878.728 -12.92%
2021 629.879.334.779 -6.61%
2022 614.476.876.092 -2.51%
2023 469.797.838.968 -30.8%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

PT Ekadharma International Tbk Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

PT Ekadharma International Tbk General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 17.180.961.545
2013 19.878.910.672 13.57%
2014 24.097.251.720 17.51%
2015 0 0%
2016 0 0%
2017 87.410.321.586 100%
2018 100.005.031.721 12.59%
2019 110.663.062.602 9.63%
2020 101.374.579.069 -9.16%
2021 99.524.247.840 -1.86%
2022 100.064.082.894 0.54%
2023 98.003.402.328 -2.1%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

PT Ekadharma International Tbk EBITDA
Year EBITDA Growth
2012 59.571.302.631
2013 69.226.686.117 13.95%
2014 75.786.513.033 8.66%
2015 86.734.782.593 12.62%
2016 134.406.014.759 35.47%
2017 124.041.977.770 -8.36%
2018 122.288.703.622 -1.43%
2019 131.461.456.784 6.98%
2020 137.540.228.699 4.42%
2021 150.026.513.742 8.32%
2022 108.215.082.627 -38.64%
2023 71.658.554.440 -51.01%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

PT Ekadharma International Tbk Gross Profit
Year Gross Profit Growth
2012 99.929.063.440
2013 115.776.189.428 13.69%
2014 133.326.340.420 13.16%
2015 150.805.116.367 11.59%
2016 197.544.057.682 23.66%
2017 192.139.855.747 -2.81%
2018 200.819.420.354 4.32%
2019 221.219.965.538 9.22%
2020 224.010.818.923 1.25%
2021 223.513.931.377 -0.22%
2022 189.561.823.033 -17.91%
2023 152.466.904.260 -24.33%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

PT Ekadharma International Tbk Net Profit
Year Net Profit Growth
2012 35.970.304.664
2013 38.853.310.468 7.42%
2014 40.272.719.715 3.52%
2015 47.148.747.496 14.58%
2016 87.814.993.495 46.31%
2017 75.355.058.010 -16.53%
2018 72.355.265.974 -4.15%
2019 73.765.183.109 1.91%
2020 93.502.477.372 21.11%
2021 104.409.665.421 10.45%
2022 76.720.824.809 -36.09%
2023 47.190.838.184 -62.58%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

PT Ekadharma International Tbk Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 10
2013 11 9.09%
2014 12 0%
2015 13 15.38%
2016 25 48%
2017 22 -19.05%
2018 21 -5%
2019 21 4.76%
2020 27 19.23%
2021 30 10.34%
2022 22 -38.1%
2023 14 -61.54%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

PT Ekadharma International Tbk Free Cashflow
Year Free Cashflow Growth
2012 9.704.902.222
2013 -6.335.091.807 253.19%
2014 -7.999.137.675 20.8%
2015 90.464.305.085 108.84%
2016 42.733.802.835 -111.69%
2017 19.802.360.512 -115.8%
2018 17.472.612.929 -13.33%
2019 85.491.530.718 79.56%
2020 220.619.536.920 61.25%
2021 33.935.807.529 -550.11%
2022 87.080.244.086 61.03%
2023 -10.712.304.296 912.9%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

PT Ekadharma International Tbk Operating Cashflow
Year Operating Cashflow Growth
2012 28.582.923.169
2013 23.212.236.950 -23.14%
2014 4.641.305.865 -400.12%
2015 100.935.448.358 95.4%
2016 84.490.481.400 -19.46%
2017 51.605.876.745 -63.72%
2018 57.726.147.295 10.6%
2019 115.559.223.532 50.05%
2020 231.776.954.118 50.14%
2021 46.049.269.613 -403.32%
2022 96.207.941.831 52.14%
2023 -6.651.636.602 1546.38%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

PT Ekadharma International Tbk Capital Expenditure
Year Capital Expenditure Growth
2012 18.878.020.947
2013 29.547.328.757 36.11%
2014 12.640.443.540 -133.75%
2015 10.471.143.273 -20.72%
2016 41.756.678.565 74.92%
2017 31.803.516.233 -31.3%
2018 40.253.534.366 20.99%
2019 30.067.692.814 -33.88%
2020 11.157.417.198 -169.49%
2021 12.113.462.084 7.89%
2022 9.127.697.745 -32.71%
2023 4.060.667.694 -124.78%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

PT Ekadharma International Tbk Equity
Year Equity Growth
2012 191.977.807.039
2013 237.707.561.355 19.24%
2014 267.906.054.011 11.27%
2015 291.961.416.611 8.24%
2016 592.004.807.725 50.68%
2017 662.817.725.465 10.68%
2018 724.582.501.247 8.52%
2019 852.543.550.822 15.01%
2020 952.362.557.662 10.48%
2021 1.030.399.446.064 7.57%
2022 1.112.843.644.627 7.41%
2023 1.101.106.107.611 -1.07%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

PT Ekadharma International Tbk Assets
Year Assets Growth
2012 273.893.467.429
2013 343.601.504.089 20.29%
2014 411.726.182.748 16.55%
2015 389.691.595.500 -5.65%
2016 702.508.630.708 44.53%
2017 796.767.646.172 11.83%
2018 853.267.454.400 6.62%
2019 968.234.349.565 11.87%
2020 1.081.979.820.386 10.51%
2021 1.165.564.745.263 7.17%
2022 1.221.291.885.832 4.56%
2023 1.223.192.026.177 0.16%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

PT Ekadharma International Tbk Liabilities
Year Liabilities Growth
2012 81.915.660.390
2013 105.893.942.734 22.64%
2014 143.820.128.736 26.37%
2015 97.730.178.889 -47.16%
2016 110.503.822.983 11.56%
2017 133.949.920.707 17.5%
2018 128.684.953.153 -4.09%
2019 115.690.798.743 -11.23%
2020 129.617.262.724 10.74%
2021 135.165.299.199 4.1%
2022 108.448.241.205 -24.64%
2023 122.085.918.566 11.17%

PT Ekadharma International Tbk Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
160.63
Net Income per Share
18.74
Price to Earning Ratio
13.34x
Price To Sales Ratio
1.56x
POCF Ratio
9.3
PFCF Ratio
9.42
Price to Book Ratio
0.82
EV to Sales
0.81
EV Over EBITDA
4.9
EV to Operating CashFlow
4.84
EV to FreeCashFlow
4.91
Earnings Yield
0.07
FreeCashFlow Yield
0.11
Market Cap
873 Bil.
Enterprise Value
455 Bil.
Graham Number
359.1
Graham NetNet
120.89

Income Statement Metrics

Net Income per Share
18.74
Income Quality
1.43
ROE
0.06
Return On Assets
0.05
Return On Capital Employed
0.06
Net Income per EBT
0.81
EBT Per Ebit
1.14
Ebit per Revenue
0.14
Effective Tax Rate
0.18

Margins

Sales, General, & Administrative to Revenue
0.18
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.31
Operating Profit Margin
0.14
Pretax Profit Margin
0.15
Net Profit Margin
0.12

Dividends

Dividend Yield
0.04
Dividend Yield %
3.6
Payout Ratio
0.53
Dividend Per Share
9

Operating Metrics

Operating Cashflow per Share
26.89
Free CashFlow per Share
26.53
Capex to Operating CashFlow
-0.01
Capex to Revenue
-0
Capex to Depreciation
-0.06
Return on Invested Capital
0.06
Return on Tangible Assets
0.05
Days Sales Outstanding
43.36
Days Payables Outstanding
20.17
Days of Inventory on Hand
142.78
Receivables Turnover
8.42
Payables Turnover
18.09
Inventory Turnover
2.56
Capex per Share
-0.35

Balance Sheet

Cash per Share
119,85
Book Value per Share
305,77
Tangible Book Value per Share
315.1
Shareholders Equity per Share
305.77
Interest Debt per Share
0.01
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-4.52
Current Ratio
9.32
Tangible Asset Value
1.101 Bil.
Net Current Asset Value
562 Bil.
Invested Capital
0
Working Capital
611 Bil.
Intangibles to Total Assets
0
Average Receivables
67 Bil.
Average Payables
27 Bil.
Average Inventory
153540641701
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

PT Ekadharma International Tbk Dividends
Year Dividends Growth
2006 13
2007 3 -300%
2008 2 -50%
2009 3 33.33%
2010 3 0%
2011 8 62.5%
2012 7 -14.29%
2013 8 12.5%
2014 9 11.11%
2015 9 0%
2016 10 10%
2017 16 37.5%
2018 18 11.11%
2019 30 40%
2020 35 14.29%
2021 45 22.22%
2022 50 10%
2023 9 -455.56%

PT Ekadharma International Tbk Profile

About PT Ekadharma International Tbk

PT Ekadharma International Tbk, together with its subsidiaries, manufactures and markets self-adhesive tapes in Indonesia and Malaysia. The company offers aluminum foil and anti-slip tape; cling wrap, double foam, cloth, and double side tape; epoxy glue, kraft, masking, metalizing tape, OPP, OPP printing, PVC electrical insulation, and stationary tapes; stretch film; and water glue, white glue, super glue, and glue stick under the DAIMARU, SUPERFIX, and EKATAPE brands. It also provides adjustable carton sealer with fold flap closer; top drive, side drive, and random semi-automatic carton sealers; and semi-automatic stretch wrappers under the BESTPACK brand. The company was formerly known as PT Ekadharma Widya Grafika and changed its name to PT Ekadharma International Tbk in 2006. The company was founded in 1981 and is headquartered in Tangerang, Indonesia. PT Ekadharma International Tbk is a subsidiary of PT Ekadharma Inti Perkasa.

CEO
Ms. Judi Widjaja Leonardi
Employee
553
Address
Kawasan Industri Pasar Kemis Blok C-1
Tangerang, 15560

PT Ekadharma International Tbk Executives & BODs

PT Ekadharma International Tbk Executives & BODs
# Name Age
1 Ms. Lie Phing
Finance & Admin Director, Corporate Secretary and Director
70
2 Ade Fitriani Herawati
Accounting Manager
70
3 Ms. Judi Widjaja Leonardi
President Director
70
4 Denny Purnama Adi Chandra
Credit & Collection Manager
70
5 Dominicus Da Silva
HRD Manager
70

PT Ekadharma International Tbk Competitors